Active Biotech
Manufacturing · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Scheelevagen 22, Lund, Skane, 220 07, Sw...Phone Number
+46 46192000Website
www.activebiotech.comRevenue
<$5 MillionStock Symbol
BTPCIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Active Biotech
Active Biotech is focused on developing new treatments for cancer and inflammatory eye diseases, utilizing their extensive knowledge and previously generated documentation. Their project portfolio includes small orally active immunomodulatory molecules and antibody-based immunotherapy, with a focus on hematological cancers, non-infectious uveitis, and solid tumors. The company is actively involved in clinical studies for their key products, including tasquinimod, laquinimod, and naptumomab, in collaboration with various partners. Their intended clients include healthcare professionals and patients in need of innovative therapies for serious medical conditions.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Active Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Active Biotech has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Active Biotech has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Active Biotech had a recent Job posting/layoffs
Active Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Active Biotech launches new products
Earning: See what the market has to say on Active Biotech recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Active Biotech
Check out if Active Biotech is spiking on competitors!
Recommended Actions
Find VP level buyers at Active Biotech
Find 3 more new buyers
Company Profile Activity
Activity Insights
Active Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Active Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Active Biotech.
Active Biotech Tech Stack
A closer look at the technologies used by Active Biotech
Active Biotech News & Media
Successful completion of the first stage of the phase IIa clinical trial of naptumomab in combination with docetaxel and the study is now enrolling into the second stage
Lund, June 1, 2022 - Active Biotech (NASDAQ STOCKHOLM: ACTI) and its partner NeoTX announce today the successful completion of the first stage of a Simon 2 stage phase IIa clinical trial of naptumomab estafenatox (NAP, naptumomab), in combination with docetaxel in patients with advanced or metastatic non-small cell lung cancer (NSCLC) who have been previously treated with chemotherapy and checkpoint inhibitors (CPIs). In the study, the patients are treated with NAP for 4 consecutiveAnnual General Meeting of Active Biotech AB
The Annual General Meeting of Active Biotech was held on May 19, 2022. Due to the situation resulting from the Corona virus, the Meeting was carried out through postal voting, without any physical attendance. The following main resolutions were passed.FDA grants Orphan Drug Designation for tasquinimod in myelofibrosis
Lund May 18, 2022 - Active Biotech AB (Nasdaq Stockholm: ACTI) today announced that the U.S. Food and Drug Administration (FDA) has granted tasquinimod Orphan Drug Designation for the treatment of myelofibrosis.Annual Report 2021 Active Biotech AB (publ)
Active Biotech's Annual Report 2021 is now available for download at www.activebiotech.com. The Annual Report will only be digitally distributed.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Active Biotech
Sign Up For FreeTo access detailed company insights
Active Biotech is focused on developing new treatments for cancer and inflammatory eye diseases, utilizing their extensive knowledge and previously generated documentation. Their project portfolio includes small orally active immunomodulatory molecules and antibody-based immunotherapy, with a focus on hematological cancers, non-infectious uveitis,... Read More
